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Background and objective: Asthma is one of the most common chronic diseases among
women of reproductive age, and previous studies have suggested a link between female
asthma and infertility. The aim of the present review is to provide an update on current
knowledge of the association between female asthma and/or atopy and a reduction in fertility,
ie, number of offspring, time to pregnancy (TTP) and need for fertility treatment.
Methods: Systematic review performed in accordance with the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses-guidelines.
Results: A total of 14 studies fulﬁlled the predeﬁned criteria for inclusion in the present review.
Six studies investigated the association between female asthma and/or atopy and number of
offspring, of which one reported a positive, two a negative, and three no association. Three
studies addressed the association between asthma and TTP and found that TTP was signiﬁcantly
prolonged in asthmatic women compared to non-asthmatic women. Five studies investigated
subfertility and the need for fertility treatments of which two studies found a higher prevalence of
infertility among women prescribed anti-asthma medication. One study found no difference in
the number of fertility treatments of asthmatic women compared to non-asthmatic women,
whereas three studies reported that female asthma was associated with signiﬁcantly more fertility
treatment compared to non-asthmatic women.
Conclusion: Although the available evidence is conﬂicting, there is a clear trend toward an
association between female asthma and a reduction in fertility, and by that a larger proportion
requiring fertility treatment, even though female asthma might not negatively affect total
number of offspring.
Keywords: asthma, fertility, offspring, fertility treatment, time to pregnancy
Introduction
Asthma is one of the most common chronic diseases among women of reproductive
age,1 and previous studies have shown that there might be a link between asthma
and a reduction in fertility.2,3
Asthma with or without concomitant atopy is an inﬂammatory disease and the
inﬂammatory changes may have an effect outside the respiratory system. It has
been hypothesized that the inﬂammation may affect the reproductive organs, and by
that have an impact on various phases of the reproductive cycle, not least the
receptiveness of the uterus at it may lead to inﬂammatory changes in the endome-
trium. Lower levels of vascular endothelial growth factor (VEGF) have been found
in asthmatic women with unexplained infertility,4 and this might have a negative
impact on the receptiveness of the endometrium.
Other inﬂammatory diseases, such as rheumatoid arthritis have been linked to
infertility or subfertility.5,6 However, the cause of reduced fertility in rheumatoid
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arthritis appears to be multifactorial and related to disease
activity and medical therapy, including methotrexate and
systemic corticosteroid, although there is so far no clear
evidence for an association between a reduction in fertility
and systemic corticosteroid therapy.5 On the other hand, in
inﬂammatory bowel diseases, no evidence has been found
for physiological causes of infertility.7–11 Hence, there is
no clear picture of the possible association between
inﬂammatory diseases, in general, and reduced fertility.
The aim of the present review is to provide an update
on current knowledge of fertility in women with asthma
and the possible association between maternal asthma and
a reduction in fertility, primarily focusing on the number
of children, time to pregnancy (TTP), and fertility
treatment.
Methods
This review was conducted in accordance with the Preferred
Reporting Items for Systematic reviews and Meta-Analyses-
Statement.12 A series of systematic searches were performed,
using the PubMed database. The searches were last updated
in January 2019.
The strategy was to assemble as much literature about
female asthma and fertility as possible, to explore the
association between female asthma and fertility.
The search algorithm consisted of whole words and
short terms combined with Medical Subject Headings
(MeSH) terms, and were carried out using the following
algorithm: “Asthma AND fertility” OR “Asthma AND
subfertility” OR “Asthma AND infertility” OR “Asthma
AND parity” OR “Asthma AND age at pregnancy”.
Publications were included if: 1) investigating the
effect of female asthma on fertility, 2) reporting observa-
tions from original studies, 3) database or cohort studies
(either prospective or retrospective in design), but
excluded if: 1) reporting other reasons for impaired ferti-
lity, 2) non-original research paper, ie, reviews, and 3)
non-English paper; further details are given in Figure 1.
Results
The search algorithm provided 2196 hits of which 14
studies fulﬁlled the predeﬁned criteria and were included
in the present review (Figure 1). Six studies (n=517,613)
investigated the association between number of offspring
and asthma, three studies (n=21,112) investigated the asso-
ciation between TTP and asthma, and ﬁve studies
(n=1,039,893) investigated subfertility and the need of
fertility treatment in asthmatic women.
Number of offspring in women with
asthma and/or atopy
In 1997, based on the International Study of Asthma and
Allergy in Children study, Nilsson et al,13 investigated the
number of offspring among atopic and non-atopic mothers.
Two groups of children were included, group 1 comprised
2338 children aged 13–14 years and group 2 comprised
1329 children 7 years of age. A questionnaire focusing on
family history, allergy, smoking habits, and living condi-
tions was completed by the parents. Maternal atopy was
deﬁned as an afﬁrmative response to questions related to
asthma, allergic rhinitis, hay fever and/or itching ﬂexural
dermatitis, using both terms of allergic rhinitis and hay
fever. The study revealed that atopic mothers had more
children than non-atopic mothers (2.18 children vs 1.97
children, p<0.001, in group 1 and 2.17 children vs 1.99
children, p<0.017, in group 2).
Based on data from the European Community Health
Survey (ECRHS), Sunyer et al,14 assessed the association
between number of offspring and atopy. ECRHS is an
international survey carried out during 1991–1992 in ran-
domly selected individuals from the general population
aged 20–44 years in 16 countries (ECRHS-I), with a
follow-up survey (ECRHS-II) carried out in 1999–2002.
2,196 hits
(Pubmed-database)
The effect of female asthma on 
fertility (n=16)
Studies fulfilling the predefined 
criteria
(n=14)
Excluded:
Studies not addressing 
the effect of female 
asthma on fertility 
(n=2,181)
Excluded:
Review articles (n=2)
Figure 1 Consort diagram showing the study selection process.
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Out of 4580 women participating in ECRHS-I, a total of
2844 women (62.1%) completed the follow-up question-
naire in ECRHS-II. Atopy was deﬁned as the presence of
speciﬁc IgE toward house dust mite, cat dander, timothy
grass, and/or Cladosporium herbarum, and asthma was
deﬁned based on afﬁrmative responses to respiratory
symptoms obtained from the International Union Against
Tuberculosis and Lung Disease questionnaire.15,16 At
baseline, the number of offspring was higher in non-atopic
women than in atopic women (1.38 and 1.19, p<0.01). At
the follow-up, there was no difference in the number of
offspring between non-atopic and atopic women (1.79 and
1.75, p=0.35).
In a register-based twin study using data from the
Danish Twin Registry, Gade et al,17 investigated if asthma
affected TTP and fertility. Asthma was deﬁned as an
afﬁrmative answer to the question “Have you ever had
asthma?”. Allergy was deﬁned as an afﬁrmative answer
to the question “Have you ever had allergy?”. A total of
15,250 females answered the questionnaire of whom 955
reported a history of asthma. Approximately 8000 women
did not respond to the questions related to fertility, with
non-responders being younger than the responders (22.3 vs
32.0 years). Gade et al,17 found no difference in the
number of offspring in women with and without asthma
(1.86 vs 1.83; p=0.51). In contrast to previous observa-
tions, the study showed that females with asthma con-
ceived earlier in life (23.7 vs 24.5 years; p<0.001) and
were younger when giving birth for the ﬁrst time (25.5 vs
26.2 years; p=0.001) compared to females without asthma.
In a population study based on a primary care database
from general practices across England and Wales, Tata et
al,18 investigated the fertility rates in females aged 15–44
years. Females were included from 1994 to 2004 if they
had a diagnosis of allergic disease, including asthma, hay
fever, and eczema (n=491,516). In total, 13%, 14%, and
12%, respectively, had a diagnosis of asthma, eczema, and
hay fever. The study revealed that females with asthma
had a fertility rate of 53.0 livebirths per 1000-person years
vs 52.3 livebirths per 1000-person years in females with-
out asthma (adjusted fertility rate ratio (FRR) =1.02, 95%
CI: 1.00–1.04). Furthermore, the study also showed that
females with asthma aged 20–29.9 years had more chil-
dren (20–24.9 years FRR =57.8, 95% CI: 55.6–60.1; 25–
29.9 years FRR =89.3, 95% CI: 86.4–92.3) compared to
non-asthmatic females (20–24.9 years FRR =49.1, 95%
CI: 48.2–50.0; 25–29.9 years FRR =79.4, 95% CI: 78.3–
80.5) and the fertility rates were higher in females with
eczema (59.4 vs 51.0 livebirths per 1000 person years,
adjusted FRR =1.15, 95% CI: 1.13–1.17) and hay fever
(57.7 vs 51.5 livebirths per 1000 person years, crude FRR
=1.08, 95% CI: 1.06–1.10) compared to females without
eczema and hay fever, suggesting no impairment of ferti-
lity in females with a doctor diagnosis of asthma, hay
fever, or eczema.
Karmaus et al,3 investigated the association of maternal
atopy and number of offspring in two different surveys
based on the German part of the European Studies on
Infertility and Subfecundity. In one survey, termed the
pregnancy-based survey, females admitted to maternity
ward in 1992 (n=1318) ﬁlled-in self-administered ques-
tionnaires. In the other survey conducted from 1991 to
1992, termed the population-based survey, women aged
25–44 (n=1531) were identiﬁed using population registers
and interviewed by trained interviewers using the same
questionnaire supplemented by additional questions relat-
ing to prior pregnancies. The study revealed that females
with atopic manifestations as asthma, hay fever, or atopic
eczema had less children compared to females without
atopic manifestations in both the pregnancy-based survey
(OR=0.75, 95% CI: 0.57–0.98) and the population-based
survey (OR=0.79, 95% CI: 0.63–0.99). The proportion of
mothers with atopic manifestations was higher in the
population-based survey than the pregnancy-based survey
(29.5% vs 21.0, respectively).
In three concurrent cohorts, Sunyer et al,2 studied
maternal atopy and parity. They recruited mothers
(n=1487) and their children to the Asthma Multicenter
Infants Cohort Study in Ashford, Kent, UK (1994–1995),
Menorca Island, Spain (1997–1998), and Barcelona, Spain
(1996–1998). Atopy was identiﬁed by skin prick tests and
information on different variables, eg, having asthma and
total number of live children, was obtained by question-
naires. Asthma and hay fever, respectively, were deﬁned as
an afﬁrmative answer to the question “Have you ever had
asthma?” and “Have you ever had hay fever or allergic
rhinitis?”. The studies revealed that atopic women had less
children than non-atopic women (p for trend =0.002)
whereas no relation was found between number of off-
spring and maternal asthma (p for trend =0.43).
The results on the number of offspring in women with
asthma and/or atopy are conﬂicting. Two studies found an
increase in number of offspring in atopic women com-
pared to non-atopic women,13,18 two studies found no
difference,14,17 one study found a decrease in number of
offspring in women with asthma or atopic symptoms,3 and
Dovepress Bláfoss et al
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lastly one study found that atopic women had less children
than healthy women though no relation between asthma
and number of offspring was found.2 Only one of the six
studies had a doctor diagnosis of asthma or allergy from a
database,18 whereas the remaining studies2,3,13,14,17 relied
on questionnaires, of which at least three used afﬁrmative
answers to questions like “Have you ever had asthma” or
“Have you ever had allergy”.2,13,17 Two of the studies
identiﬁed atopy by the presence of speciﬁc IgE or positive
skin prick tests,2,14 and one study used trained
interviewers.3 The discrepancy in results is therefore likely
to be caused by differences in methodology, as registered
diagnosis and laboratory test are likely to be more reliable
compared to questionnaire. The difference in observations
in the two surveys by Sunyer et al,14 could be due to the
fact that data were missing for more than one-third of the
women participating in the ﬁrst survey and only 62% of
the women participated in the follow-up survey.
Furthermore, atopic women were younger at baseline
than the non-atopic women. Additionally, Gade et al,17
also had a high proportion of non-responders that poten-
tially can bias the results. The non-responders were
younger than the responders, and the study found that
women with asthma conceived earlier than non-asthmatic
women. It could, therefore, be argued that the high number
of non-responders was due to a lower age of the women.
Presently, it is, therefore, difﬁcult to draw valid conclu-
sions with regard to the impact of female asthma and/or
atopy on total number of offspring.
Time to pregnancy
In the register-based twin study (described above), Gade et
al,17 also investigated TTP and found TTP to be signiﬁcantly
prolonged in asthmatic females compared to non-asthmatic
females (27.0% vs 21.6%, p=0.009). In asthmatic females
>30 years of age, TTP was even more prolonged (32.2% vs
24.9%, p=0.04). Furthermore, asthmatic females not pre-
scribed asthma therapy had a signiﬁcantly increased risk of
prolonged TTP compared to non-asthmatic females (30.5%
vs 21.6%, p=0.0004), and the same was found for asthmatic
females prescribed inhaled corticosteroids (ICS) compared to
non-asthmatics (33.0% vs 21.6%, p=0.003). However, asth-
matics receiving any kind of asthma treatment tended to have
shorter TTP than untreated asthmatics though this did not
reach statistical signiﬁcance (23.8% vs 30.5%, p=0.134).
Furthermore, the study revealed that females with allergy
had the same TTP as the general population (21.2% vs
21.6%; OR 0.91, 95% CI 0.76–1.10) and females with
asthma and allergy had a slightly, not statistically signiﬁ-
cantly, prolonged TTP (26.5% vs 21.6%; OR 1.28, 95% CI
0.96–1.72).
In a clinical observational study, Gade et al,19 investi-
gated women (n=245) with unexplained infertility who
were undergoing fertility treatments from 2011 to 2013.
At a screening visit, the women were interviewed and
objectively assessed for asthma and allergy including
lung function test, methacholine and/or mannitol challenge
test, measurement of exhaled nitric oxide fraction, skin
prick test, and blood samples. Of the 245 women, 81
were found to have current asthma. The study revealed
that asthmatic women had a signiﬁcantly prolonged TTP
compared to non-asthmatics (55.6 months vs 32.3 months,
p<0.001), also after adjusting for age, body mass index
(BMI), former smoking, age at menarche, previous preg-
nancies/births, semen quality and motility, and number of
treatment cycles received in fertility treatment (p=0.003).
Females >35 years of age were less likely to conceive
compared to females <35 years of age (25.9 vs 61.4%,
p<0.001). There was no signiﬁcant difference in TTP in
women with treated asthma vs women with untreated
asthma (HR 1.13, 95% CI 0.60–2.15, p=0.706).
In the Screening for Pregnancy endpoints study,
Grzeskowiak et al,20 recruited healthy nulliparous women
(n=5617) and investigated the impact of asthma and asthma
medication on fecundability and TTP. The study was a
multicenter multinational prospective cohort study carried
out in Auckland (New Zealand), Adelaide (Australia), Cork
(Ireland), Manchester and London (United Kingdom) and
the women were recruited between November 2004 and
February 2011. Asthma was deﬁned by the question
“Have you been diagnosed with asthma by a doctor?” Of
the 5617 included women, 1106 reported doctor-diagnosed
asthma and these women were divided into subgroups clas-
siﬁed as former asthmatics (doctor diagnosed, but no symp-
toms and no asthma medication within the last 12 months)
and current asthmatics (doctor diagnosed with symptoms
and use of asthma reliever or controller medication within
the last 12 months), with the latter group further sub-divided
based on type of asthma medication into intermittent
asthma (use of reliever medication, ie, short-acting β2-ago-
nist, only) and persistent asthma (use ofICS with or without
long-acting β-agonists. TTP was self-reported and deﬁned
as the duration of pre-conception sex (in months) without
the use of contraceptives and subfertility was deﬁned as
TTP >12 months. Grzeskowiak et al, reported that the group
of current asthmatics using only reliever therapy (n=421)
Bláfoss et al Dovepress
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had a fecundability odds ratio (FORs) of 0.85 (95% CI
0.75–0.96) compared to non-asthmatics, the group of cur-
rent asthmatics using controller medication (n=235) had a
FORs of 0.98 (95% CI 0.84–1.15) and former asthmatics
(n=450) had a FORs of 1.00 (95% CI 0.89–1.13) compared
to non-asthmatics. Their ﬁndings revealed a reduction in
fecundity, or prolonged TTP, (FORs <1) in asthmatic
women only using rescue medication for asthma compared
to non-asthmatic women. On the other hand, no signiﬁcant
difference in fecundity was found between women with
former asthma or current asthmatic women on controller
medication compared to non-asthmatic women. However,
the women with both former and current asthma on con-
troller medication were younger, had a higher BMI, were
more likely to smoke, be of Caucasian ethnicity and have a
lower socioeconomic status. Furthermore, the self-reported
diagnosis of asthma and TTP may be considered as a weak-
ness, whereas objective data on asthma medication,
although not reported in detail, is likely to strengthen the
identiﬁcation of women with asthma.
In both studies, Gade et al,17,19 found prolonged TTP in
asthmatic women compared to non-asthmatic women. In
contrast to Grzeskowiak et al,20 the studies by Gade et al,17,19
did not observe any signiﬁcant differences in TTP in women
prescribed asthma medication. Unfortunately, the register-
based twin study17 had a high proportion of non-responders,
whereas in the observational study,19 the extensive examina-
tion of the participants is a clear strength of the study.
However, as a single center study, the included women
might not be fully representative according to factors such
as socioeconomic class and lifestyle. The currently available
studies suggest that women with asthma have prolonged
TTP, which is probably not caused by potential adverse
effects of asthma medication.
Subfertility and need for fertility
treatment
In a case–control study, Grodstein et al,21 investigated the
association between the use of pharmaceuticals and infer-
tility in the United States and Canada. The study focused
on women with ovulatory dysfunction as a cause of infer-
tility (n=597) compared to women admitted for delivery of
a livebirth at hospitals (n=3833). Trained nurses inter-
viewed the women and collected information on medical
history, use of contraceptives, reproductive history and
personal habits. The study revealed that women who had
used asthma medication for more than 6 months had an
increased risk of infertility (RR 1.7, 95% CI 0.7–3.5). The
risk was 2.5 (95% CI 1.0–5.9) for women prescribed
asthma medication before the age of 21 in contrast to 0.5
(95% CI 0.0–2.8) for women prescribed asthma medica-
tion at an older age. Furthermore, the study showed that
the risk of ovulatory infertility was signiﬁcantly increased
in women using beta-agonists (RR 3.2, 95%CI 0.8–11) but
only slightly increased in women treated with theophylline
(RR 1.2, 95% CI 0.3–3.2).
In the clinical study (described above) of women with
unexplained infertility by Gade et al,19 asthmatic women
were less likely to conceive than non-asthmatic women,
especially in women >35 years of age compared to women
<35 years (25.9% vs 61.4%, p<0.001). The pregnancy
rates for non-asthmatic women >35 years of age was
56.7% and for women <35 years 80.6%. Furthermore,
there was no difference in number of fertility treatments
in the asthmatic group and the non-asthmatic group
(p=0.862).
In a register study based on the Swedish Medical Birth
Register from 1995 to 2004, Källén et al,22 investigated
the use of anti-asthmatic drugs in the ﬁrst trimester of
pregnancy and during pregnancy. The study included
women that reported the use of anti-asthmatic drugs
early in pregnancy (n=24,368), women prescribed anti-
asthmatic drugs later in pregnancy (n=7778), with all
women (n=860,215) used as controls. Information regard-
ing subfertility was obtained from the ﬁrst prenatal visit to
the midwife. The study revealed that women using anti-
asthmatic drugs had experienced a period of subfertility
and the association was stronger for women receiving
drugs later during pregnancy than for women who used
drugs early in pregnancy (OR 1.45, 95% CI 1.34–1.57 vs
OR 1.19, 95% CI 1.14–1.25), however, the pattern of drug
use for asthma was not reported in detail.
In a retrospective population-based study, Sheiner et al,23
investigated singleton pregnancies in mothers with and with-
out asthma based on deliveries in southern Israel during the
years 1988–2002. The diagnosis of asthma was based on the
patient’s chart and patients with less than three visits in the
prenatal care were excluded. A total of 139,168 singleton
deliveries were included during the period and 1.4% were
deliveries of asthmatic mothers. The study revealed that
asthmatic mothers had signiﬁcantly more fertility treatments
compared to non-asthmatic mothers (3.3% vs 1.8%,
p<0.001). The study also found that the maternal age was
signiﬁcantly higher in asthmatic mothers compared to the
non-asthmatic mothers (29.1±5.7 vs 28.4±5.8, p<0.001).
Dovepress Bláfoss et al
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Avery recent case–control study by Vejen Hansen et al,24
explored the association between asthma and need for ferti-
lity treatment among women with life births. The sample
comprised women with asthma (n=932) and non-asthmatic
matched controls (n=2757), of whom 12% (n=114) and 8%
(n=212), respectively, had fertility treatment (OR 1.67, 95%
CI 1.32–2.13; p<0.001). Furthermore, this association
between female asthma and need for fertility treatment
remained signiﬁcant after adjusting for age, BMI, and smok-
ing habits; and subdividing the cohort according to age
showed that in women ≥35 years, 25% (n=63) and 13%
(n=82) among case and controls, respectively, had fertility
treatment (OR 2.12, 95% CI 1.47 to 3.07; p<0.001). Of note
is that 64% of the enrolled women with asthma were pre-
scribed ICS either as monotherapy or in combination with a
long-acting beta2-agonist (22% of the sample), suggesting
that the majority of the sample had mild to moderate asthma.
The current evidence seems somewhat contradicting, as
Sheiner et al,23 found that asthmatic women had more
fertility treatments than non-asthmatic women, whereas
Gade et al,19 found no evidence of the need of more fertility
treatments. However, compared to previous observations,
that asthma affects up to 10% of the women of childbearing
age,1 the proportion of asthmatic women in the study by
Sheiner et al,23 is markedly lower. It could be hypothesized
that there might be women with undiagnosed asthma
included in the study which might bias the results.
However, the study by Gade et al,19 recruited a selected
group of women with unexplained infertility, and the obser-
vation of more need for fertility treatment among women
with asthma by Sheiner et al,23 is strongly supported by the
observations in the study by Vejen Hansen et al,24
Furthermore, in the study by Källén et al,22 the results are
based on the women’s perceived experience of subfertility
without any given deﬁnitions of subfertility. Overall, the
current evidence points toward a higher need for fertility
treatment among women with asthma, possibly irrespective
of severity of the disease.
Discussion
The present review revealed that two out of six studies looking
at number of offspring reported that women with asthma or
atopic symptoms had less children than healthy women.2,3
Three studies foundnodifference in number of offspring14,17,18
and one study found that atopic women hadmore children than
non-atopic women.13 In the investigation of TTP in asthmatic
women, all three studies included found prolonged TTP17,19,20
but found conﬂicting results regarding the effect of asthma
medication on TTP as two studies found no signiﬁcant differ-
ence in the prolonged TTP in treated asthmatic women com-
pared to untreated asthmatic women,17,19 and one study20
found no signiﬁcant difference in TTP in asthmatic women
prescribed controller medication compared to non-asthmatic
women. In the need of fertility treatments, the included
studies19,23,24 reported different outcomes. One study19 found
no difference in the number of fertility treatments in asthmatic
and non-asthmatic women, whereas the two other studies
reported that asthmatic women had signiﬁcantly more fertility
treatments.23,24 One study reported that women using asthma
medication reported having experienced a period of
subfertility.21
Reviewing the available evidence reveals inconsisten-
cies in ﬁndings. First of all, there is a variation in the
deﬁnition of atopy and asthma. Some studies use afﬁrma-
tive answers to questions related to previous diagnoses and/
or symptoms,3,13,17,20,21 while other base the diagnosis on
the women’s medical records or objective tests18,19,22–24 or
a combination of tests and questions.2,14 Second of all, there
is a difference in how speciﬁc a disease is deﬁned, some
studies address women with atopic manifestations,13 others
asthma17,20–24 and some look at both asthma and atopic
manifestations.2,3,14,17–19 Further studies of more well-
characterized cohorts are, therefore, needed in order to
obtain more accurate information on the association
between asthma and/or atopic disease and fertility.
Furthermore, there also seem to be inconsistencies in the
observations with regard to atopic and non-atopic asthma, as
the studies have reported that atopic asthma does not affect
fertility, whereas non-atopic asthma tends to have a negative
effect on fertility. At present, the underlying mechanisms for
these observations are unknown, but it may be caused by
differences in nature of inﬂammation, and the observations,
therefore, clearly calls for further studies addressing the
possible association between type of inﬂammation, including
systemic inﬂammation, possible inﬂammatory changes in the
uterus together with the effect of levels of VEGF, in women
with atopic and non-atopic asthma and fertility.
In conclusion, although the studies have produced con-
ﬂicting results, the presently available studies clearly sug-
gest an association between female asthma and a reduction
in fertility, not least in women toward the end of the
reproductive age and perhaps also non-atopic asthma,
although the evidence so far does not clearly answer the
question of whether or not female asthma and/atopy has an
impact on total number of offspring. The underlying
mechanisms are largely unknown and further investigation
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needs to be done on how female asthma affects the repro-
ductive organs and fertility, also in relation to the level of
asthma therapy. Furthermore, studies on interventions aim-
ing at reducing probably both airway and systemic inﬂam-
mation, including in the uterus, are clearly needed in order
to improve fertility in women with asthma.
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